120 related articles for article (PubMed ID: 9823954)
1. In AML t(8;21) colony growth of both leukemic and residual normal progenitors is restricted to the CD34+, lineage-negative fraction.
Wittebol S; Raymakers R; van de Locht L; Mensink E; de Witte T
Leukemia; 1998 Nov; 12(11):1782-8. PubMed ID: 9823954
[TBL] [Abstract][Full Text] [Related]
2. Residual normal, highly proliferative progenitors can be isolated from the CD34+/33- fraction of AML with a more differentiated phenotype (CD33+).
Raymakers R; Wittebol S; Pennings A; Linders E; Poddighe P; De Witte T
Leukemia; 1995 Mar; 9(3):450-7. PubMed ID: 7533867
[TBL] [Abstract][Full Text] [Related]
3. Immature CD34+CD19- progenitor/stem cells in TEL/AML1-positive acute lymphoblastic leukemia are genetically and functionally normal.
Hotfilder M; Röttgers S; Rosemann A; Jürgens H; Harbott J; Vormoor J
Blood; 2002 Jul; 100(2):640-6. PubMed ID: 12091359
[TBL] [Abstract][Full Text] [Related]
4. Phenotypical characteristics of acute myelocytic leukemia associated with the t(8;21)(q22;q22) chromosomal abnormality: frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34.
Kita K; Nakase K; Miwa H; Masuya M; Nishii K; Morita N; Takakura N; Otsuji A; Shirakawa S; Ueda T
Blood; 1992 Jul; 80(2):470-7. PubMed ID: 1378322
[TBL] [Abstract][Full Text] [Related]
5. Leukemic stem cells in childhood high-risk ALL/t(9;22) and t(4;11) are present in primitive lymphoid-restricted CD34+CD19- cells.
Hotfilder M; Röttgers S; Rosemann A; Schrauder A; Schrappe M; Pieters R; Jürgens H; Harbott J; Vormoor J
Cancer Res; 2005 Feb; 65(4):1442-9. PubMed ID: 15735032
[TBL] [Abstract][Full Text] [Related]
6. AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation.
Miyamoto T; Weissman IL; Akashi K
Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7521-6. PubMed ID: 10861016
[TBL] [Abstract][Full Text] [Related]
7. Leukemia-associated changes identified by quantitative flow cytometry. IV. CD34 overexpression in acute myelogenous leukemia M2 with t(8;21).
Porwit-MacDonald A; Janossy G; Ivory K; Swirsky D; Peters R; Wheatley K; Walker H; Turker A; Goldstone AH; Burnett A
Blood; 1996 Feb; 87(3):1162-9. PubMed ID: 8562943
[TBL] [Abstract][Full Text] [Related]
8. Molecular detection of t(8;21)/AML1-ETO in AML M1/M2: correlation with cytogenetics, morphology and immunophenotype.
Andrieu V; Radford-Weiss I; Troussard X; Chane C; Valensi F; Guesnu M; Haddad E; Viguier F; Dreyfus F; Varet B; Flandrin G; Macintyre E
Br J Haematol; 1996 Mar; 92(4):855-65. PubMed ID: 8616078
[TBL] [Abstract][Full Text] [Related]
9. Primitive AML progenitors from most CD34(+) patients lack CD33 expression but progenitors from many CD34(-) AML patients express CD33.
Vercauteren S; Zapf R; Sutherland H
Cytotherapy; 2007; 9(2):194-204. PubMed ID: 17453971
[TBL] [Abstract][Full Text] [Related]
10. AML1-ETO fusion protein up-regulates TRKA mRNA expression in human CD34+ cells, allowing nerve growth factor-induced expansion.
Mulloy JC; Jankovic V; Wunderlich M; Delwel R; Cammenga J; Krejci O; Zhao H; Valk PJ; Lowenberg B; Nimer SD
Proc Natl Acad Sci U S A; 2005 Mar; 102(11):4016-21. PubMed ID: 15731354
[TBL] [Abstract][Full Text] [Related]
11. Differences in the frequency of normal and clonal precursors of colony-forming cells in chronic myelogenous leukemia and acute myelogenous leukemia.
Bernstein ID; Singer JW; Smith FO; Andrews RG; Flowers DA; Petersens J; Steinmann L; Najfeld V; Savage D; Fruchtman S
Blood; 1992 Apr; 79(7):1811-6. PubMed ID: 1373089
[TBL] [Abstract][Full Text] [Related]
12. Detection of AML1/ETO fusion transcript as a tool for diagnosing t(8;21) positive acute myelogenous leukemia.
Maruyama F; Stass SA; Estey EH; Cork A; Hirano M; Ino T; Freireich EJ; Yang P; Chang KS
Leukemia; 1994 Jan; 8(1):40-5. PubMed ID: 7507193
[TBL] [Abstract][Full Text] [Related]
13. Acute myelogenous leukemia with t(8;21)--identification of a specific immunophenotype.
Khoury H; Dalal BI; Nevill TJ; Horsman DE; Barnett MJ; Shepherd JD; Toze CL; Conneally EA; Sutherland HJ; Hogge DE; Nantel SH
Leuk Lymphoma; 2003 Oct; 44(10):1713-8. PubMed ID: 14692523
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic analysis of CD34+ subpopulations in AML and MDS characterized by the expression of CD38 and CD117.
Haase D; Feuring-Buske M; Schäfer C; Schoch C; Troff C; Gahn B; Hiddemann W; Wörmann B
Leukemia; 1997 May; 11(5):674-9. PubMed ID: 9180291
[TBL] [Abstract][Full Text] [Related]
15. Synergistic up-regulation of the myeloid-specific promoter for the macrophage colony-stimulating factor receptor by AML1 and the t(8;21) fusion protein may contribute to leukemogenesis.
Rhoades KL; Hetherington CJ; Rowley JD; Hiebert SW; Nucifora G; Tenen DG; Zhang DE
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11895-900. PubMed ID: 8876234
[TBL] [Abstract][Full Text] [Related]
16. Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors.
Sarris AH; Talpaz M; Deisseroth AB; Estrov Z
Leukemia; 1996 May; 10(5):757-65. PubMed ID: 8656668
[TBL] [Abstract][Full Text] [Related]
17. Detection of the AML1/ETO fusion transcript in the t(8;21) masked translocation in acute myelogenous leukemia.
Maruyama F; Yang P; Stass SA; Cork A; Freireich EJ; Lee MS; Chang KS
Cancer Res; 1993 Oct; 53(19):4449-51. PubMed ID: 8402610
[TBL] [Abstract][Full Text] [Related]
18. ABCB1 modulation does not circumvent drug extrusion from primitive leukemic progenitor cells and may preferentially target residual normal cells in acute myelogenous leukemia.
Raaijmakers MH; de Grouw EP; van der Reijden BA; de Witte TJ; Jansen JH; Raymakers RA
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3452-8. PubMed ID: 16740770
[TBL] [Abstract][Full Text] [Related]
19. [The immunophenotypic analysis of CD7+ and (or) CD56+ acute myeloid leukemic stem cells and its applications in minimal residual disease detection].
Cao H; Wang YZ; Wu HH; Chang Y; Hao L; Chen SS; Huang XJ; Lu DP; Liu YR
Zhonghua Xue Ye Xue Za Zhi; 2008 Jan; 29(1):23-8. PubMed ID: 18512311
[TBL] [Abstract][Full Text] [Related]
20. CD34(+) acute myeloid and lymphoid leukemic blasts can be induced to differentiate into dendritic cells.
Cignetti A; Bryant E; Allione B; Vitale A; Foa R; Cheever MA
Blood; 1999 Sep; 94(6):2048-55. PubMed ID: 10477734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
